Marilyn Kwan to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Marilyn Kwan has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.561
-
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
Score: 0.250
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.205
-
Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control. 2015 Apr; 26(4):529-39.
Score: 0.106